The Nociception Level (NOL) Index for Pain Assessment in the Adult Intensive Care Unit

Not yet recruitingOBSERVATIONAL
Enrollment

411

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Pain, AcuteNociceptive PainBehaviorCritical Illness
Interventions
DEVICE

Nociception Level (NOL) Index

The NOL integrates multiple physiologic parameters that are captured through a finger probe with disposable sensor. These parameters include heart rate, heart rate variability, photoplethysmography pulse wave amplitude, skin conductance and temperature, and their time derivatives. All these parameters are analyzed simultaneously to provide the NOL index which can range from 0 to 100. Values \>25 were found to be indicative of nociception and related-pain in the field of anesthesia. The investigators will use the Pain Monitoring Device-200 (PMD-200)TM, which offers the multi-parametric NOL index (0-100) (Medasense Biometrics Ltd., Ramat Gan, Israel), and was approved by Health Canada for clinical use in September 2017.

All Listed Sponsors
collaborator

Jewish General Hospital

OTHER

collaborator

Maisonneuve-Rosemont Hospital

OTHER

lead

McGill University

OTHER

NCT05339737 - The Nociception Level (NOL) Index for Pain Assessment in the Adult Intensive Care Unit | Biotech Hunter | Biotech Hunter